These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 13718704)

  • 1. Studies on the mechanism of properdin--zymosan reaction. The role of polysaccharide structure in combination with properdin.
    CSEH G; SZABO I
    Acta Microbiol Acad Sci Hung; 1961; 8():181-7. PubMed ID: 13718704
    [No Abstract]   [Full Text] [Related]  

  • 2. The properdin system and immunity. XI. Studies on the interaction of zymosan with the properdin system.
    BLUM L; PILLEMER L; LEPOW IH
    Z Immun exp ther; 1959; 118():313-28. PubMed ID: 13801695
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the possibility of determination of blood properdin by means of zymosan in the serums of different animal species].
    MAZZEI D; TASCHINI P
    Policlinico Med; 1959; 66():391-401. PubMed ID: 13853881
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of properdin titers in sera of normal subjects and patients with leukemia and lymphoma by zymosan and bacteriophage assavs.
    BALTCH AL; HASSIRDJIAN A; OSBORNE W; BUNN PA
    J Lab Clin Med; 1961 Mar; 57():420-7. PubMed ID: 13686461
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the problem of the method of determination of properdin in human serum by the zymosan method].
    MASHKOV AV; MIKHAILOVA ZM
    Zh Mikrobiol Epidemiol Immunobiol; 1962 May; 33():103-8. PubMed ID: 14470783
    [No Abstract]   [Full Text] [Related]  

  • 6. [The usefulness of various zymosan preparations in determination of properdin].
    von GRAEVENITZ ; HUSMANN KH; HOEBBEL K
    Med Exp Int J Exp Med; 1960; 3():230-6. PubMed ID: 13707673
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantitative studies of the properdin-complement system. III. Kinetics of the reaction between C'3 and the properdin-zymosan complex.
    LEON MA
    J Immunol; 1958 Jul; 81(1):23-8. PubMed ID: 13563875
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the problem of nonspecific reaction of the body to the administration of the polysaccharide zymosan].
    SAMOILINA NL
    Probl Gematol Pereliv Krovi; 1961 Jan; 6():23-30. PubMed ID: 13745936
    [No Abstract]   [Full Text] [Related]  

  • 9. [Interrelations of zymosan, properdin & tumors. III. Behavior of the properdin level in benzopyrene sarcoma-bearing rats treated with zymosan].
    FUMAROLA D; MODICA F
    Tumori; 1959; 45(1):46-53. PubMed ID: 13659609
    [No Abstract]   [Full Text] [Related]  

  • 10. EVIDENCE FOR IMMUNOLOGICAL SPECIFICITY OF THE PROPERDIN SYSTEM; DEMONSTRATION, ISOLATION AND PROPERTIES OF A SERUM FACTOR WHICH INTERACTS WITH ZYMOSAN AND OTHER POLYSACCHARIDES AT 0 DEGREES CENTIGRADE.
    BLUM L
    J Immunol; 1964 Jan; 92():61-72. PubMed ID: 14139548
    [No Abstract]   [Full Text] [Related]  

  • 11. [The properdin system and its role in infection and immunity. I. The production of active preparations of zymosan].
    NIKITINA VD; KHOLCHEV NV; ANDREEVA ZM; SOKHINA AM; CHERNOKHVOSTOVA EV; PLETENEVA IL
    Zh Mikrobiol Epidemiol Immunobiol; 1960 Aug; 31():12-9. PubMed ID: 13729079
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison between properdin titers obtained in the zymosan assay and in the bacterio-phage-neutralization assay. 2. Investigation on pathological sera.
    LAURELL AB; REYN A
    Acta Pathol Microbiol Scand; 1959; 47():419-28. PubMed ID: 14414557
    [No Abstract]   [Full Text] [Related]  

  • 13. [Influencing of the serum properdin levels of patients with neoplasms by parenteral administration of zymosan].
    SZABO IK
    Orv Hetil; 1960 Feb; 101():222-5. PubMed ID: 13836258
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison between properdin titers obtained in the zymosan assay and in the bacteriophage-neutralization assay. 1. investigation on normal human sera.
    LAURELL AB; REYN A
    Acta Pathol Microbiol Scand; 1959; 47():405-18. PubMed ID: 14414558
    [No Abstract]   [Full Text] [Related]  

  • 15. A factor in rheumatoid arthritic sera interfering in the zymosan assay of properdin.
    LAURELL AB
    Acta Pathol Microbiol Scand; 1959; 45(4):392-400. PubMed ID: 13660839
    [No Abstract]   [Full Text] [Related]  

  • 16. [Influence of subcutaneously and intramuscularly administered zymosan on the properdin titer of serum and on leukocyte count in animal experiments].
    ZSEBOK Z; WACHTL I; SZY S; SELLEI G
    Orv Hetil; 1960 Feb; 101():226-9. PubMed ID: 13847797
    [No Abstract]   [Full Text] [Related]  

  • 17. The properdin system and immunity. XV. Some biologic effects of the administration of zvmosan and other polvsaccharides to rabbits, and the presence of antibodies to zymosan in human and rabbit serum.
    HINZ CF; WEDGWOOD RJ; PILLEMER L
    J Lab Clin Med; 1961 Feb; 57():185-98. PubMed ID: 13714488
    [No Abstract]   [Full Text] [Related]  

  • 18. Elevation of properdin levels in mice following administration of bacterial lipopolysaccharides.
    LANDY M; PILLEMER L
    J Exp Med; 1956 Jun; 103(6):823-33. PubMed ID: 13319594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The possible role of the properdin system in transplantable cancer; the effect of zymosan on transplantable human carcinoma.
    HERBUT PA; KRAEMER WH
    Cancer Res; 1956 Dec; 16(11):1048-52. PubMed ID: 13383472
    [No Abstract]   [Full Text] [Related]  

  • 20. [Properdin system and its role in infection and immunity. II. Determination of biological activities of zymosan].
    ANDREEVA ZM; NIKITINA VD
    Zh Mikrobiol Epidemiol Immunobiol; 1960 Nov; 31():49-53. PubMed ID: 13683406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.